LU74763A1 - - Google Patents

Info

Publication number
LU74763A1
LU74763A1 LU74763A LU74763A LU74763A1 LU 74763 A1 LU74763 A1 LU 74763A1 LU 74763 A LU74763 A LU 74763A LU 74763 A LU74763 A LU 74763A LU 74763 A1 LU74763 A1 LU 74763A1
Authority
LU
Luxembourg
Application number
LU74763A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74763A1 publication Critical patent/LU74763A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU74763A 1975-04-18 1976-04-14 LU74763A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752517771 DE2517771A1 (de) 1975-04-18 1975-04-18 Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU74763A1 true LU74763A1 (fr) 1977-01-12

Family

ID=5944669

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74763A LU74763A1 (fr) 1975-04-18 1976-04-14

Country Status (15)

Country Link
US (1) US4073934A (fr)
JP (1) JPS51131860A (fr)
AT (1) AT360182B (fr)
AU (1) AU510088B2 (fr)
BE (1) BE840872A (fr)
CA (1) CA1079725A (fr)
CH (1) CH626876A5 (fr)
DE (1) DE2517771A1 (fr)
DK (1) DK142976A (fr)
FR (1) FR2307525A1 (fr)
GB (1) GB1549047A (fr)
IE (1) IE43600B1 (fr)
LU (1) LU74763A1 (fr)
NL (1) NL7604016A (fr)
SE (1) SE7604409L (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517772A1 (de) * 1975-04-18 1976-10-28 Schering Ag Cyclopentanderivate und verfahren zu ihrer herstellung
US4268522A (en) * 1976-06-14 1981-05-19 Pfizer Inc. 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
DE2729960A1 (de) * 1977-06-30 1979-01-18 Schering Ag Neue acetylenprostaglandine und verfahren zu ihrer herstellung
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
GB2225573A (en) * 1988-09-16 1990-06-06 Ueno Seiyaku Oyo Kenkyujo Kk 13,14-dihydro-15-keto-PGFs
DE69809268T2 (de) * 1997-09-09 2003-08-28 Procter & Gamble Aromatische c16-c20-substituierte tetrahydro-prostaglandine und ihre verwendung als prostaglandin f agonisten
TR200000671T2 (tr) * 1997-09-09 2000-07-21 The Procter & Gamble Company FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
WO2000051977A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Intermediaires aldehydes pour l'elaboration de derives des prostaglandines
MXPA01008955A (es) 1999-03-05 2002-04-24 Procter & Gamble Analogos de prostaglandinas selectivas de fp no saturadas de c16.
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20050095141A1 (en) * 2003-10-30 2005-05-05 Deka Products Limited Partnership System and method for pumping fluid using a pump cassette
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
EP3176162B1 (fr) 2012-07-19 2020-05-27 Cayman Chemical Company, Inc. Composés difluorolactame en tant qu'agonistes sélectifs du récepteur ep4 destinés à être utilisés dans le traitement des maladies et affections transmises par l'ep4
SG11201507470WA (en) 2013-03-15 2015-10-29 Cayman Chemical Co Inc Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
US9914725B2 (en) 2013-03-15 2018-03-13 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
CN105392505A (zh) 2013-07-19 2016-03-09 开曼化学股份有限公司 用于促进骨生长的方法、系统和组合物
PT3456710T (pt) 2016-05-09 2021-09-02 Agc Inc Novo derivado de prostaglandina
ES2956786T3 (es) 2017-10-31 2023-12-28 Agc Inc Método para producir un derivado de prostaglandina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140427A (fr) * 1974-02-27 1975-11-11

Also Published As

Publication number Publication date
NL7604016A (nl) 1976-10-20
AU1314876A (en) 1977-10-27
BE840872A (fr) 1976-10-18
DK142976A (da) 1976-10-19
IE43600L (en) 1976-10-18
CH626876A5 (fr) 1981-12-15
JPS51131860A (en) 1976-11-16
SE7604409L (sv) 1976-10-19
AU510088B2 (en) 1980-06-05
IE43600B1 (en) 1981-04-08
ATA273976A (de) 1980-05-15
GB1549047A (en) 1979-08-01
FR2307525A1 (fr) 1976-11-12
DE2517771A1 (de) 1976-10-28
CA1079725A (fr) 1980-06-17
US4073934A (en) 1978-02-14
FR2307525B1 (fr) 1980-11-28
AT360182B (de) 1980-12-29

Similar Documents

Publication Publication Date Title
FR2307525B1 (fr)
FR2300557B1 (fr)
FR2308713B1 (fr)
AU495923B2 (fr)
JPS572619B2 (fr)
JPS5533258Y2 (fr)
JPS5747577Y2 (fr)
JPS5533167B2 (fr)
FI763693A (fr)
JPS5275967U (fr)
JPS5289660U (fr)
CH586942A5 (fr)
CH592582A5 (fr)
BG23176A1 (fr)
BG23540A3 (fr)
CH577858A5 (fr)
CH579725A5 (fr)
CH579837A5 (fr)
CH583651A5 (fr)
CH600615A5 (fr)
CH585472A5 (fr)
CH586576A5 (fr)
CH586814A5 (fr)
CH606057A5 (fr)
CH588681A5 (fr)